Adaptive Biotechnologies (ADPT) Competitors $13.08 +0.47 (+3.73%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$13.06 -0.02 (-0.11%) As of 04:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ADPT vs. TWST, TXG, VCYT, RVMD, GRFS, RYTM, LEGN, ABVX, RNA, and CYTKShould you be buying Adaptive Biotechnologies stock or one of its competitors? The main competitors of Adaptive Biotechnologies include Twist Bioscience (TWST), 10x Genomics (TXG), Veracyte (VCYT), Revolution Medicines (RVMD), Grifols (GRFS), Rhythm Pharmaceuticals (RYTM), Legend Biotech (LEGN), Abivax (ABVX), Avidity Biosciences (RNA), and Cytokinetics (CYTK). These companies are all part of the "medical" sector. Adaptive Biotechnologies vs. Its Competitors Twist Bioscience 10x Genomics Veracyte Revolution Medicines Grifols Rhythm Pharmaceuticals Legend Biotech Abivax Avidity Biosciences Cytokinetics Adaptive Biotechnologies (NASDAQ:ADPT) and Twist Bioscience (NASDAQ:TWST) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability. Do institutionals & insiders have more ownership in ADPT or TWST? 99.2% of Adaptive Biotechnologies shares are owned by institutional investors. 6.4% of Adaptive Biotechnologies shares are owned by company insiders. Comparatively, 3.0% of Twist Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is ADPT or TWST more profitable? Twist Bioscience has a net margin of -23.51% compared to Adaptive Biotechnologies' net margin of -59.07%. Twist Bioscience's return on equity of -29.03% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Adaptive Biotechnologies-59.07% -60.93% -23.03% Twist Bioscience -23.51%-29.03%-21.77% Which has higher valuation and earnings, ADPT or TWST? Adaptive Biotechnologies has higher earnings, but lower revenue than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Adaptive Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptive Biotechnologies$205.22M9.71-$159.49M-$0.82-15.95Twist Bioscience$362.27M4.29-$208.73M-$1.45-17.74 Does the media favor ADPT or TWST? In the previous week, Twist Bioscience had 17 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 23 mentions for Twist Bioscience and 6 mentions for Adaptive Biotechnologies. Adaptive Biotechnologies' average media sentiment score of 1.15 beat Twist Bioscience's score of 0.64 indicating that Adaptive Biotechnologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adaptive Biotechnologies 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Twist Bioscience 10 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend ADPT or TWST? Adaptive Biotechnologies currently has a consensus target price of $12.38, suggesting a potential downside of 5.39%. Twist Bioscience has a consensus target price of $49.40, suggesting a potential upside of 92.07%. Given Twist Bioscience's higher probable upside, analysts plainly believe Twist Bioscience is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adaptive Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.73 Which has more volatility and risk, ADPT or TWST? Adaptive Biotechnologies has a beta of 1.93, suggesting that its share price is 93% more volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 2.31, suggesting that its share price is 131% more volatile than the S&P 500. SummaryAdaptive Biotechnologies and Twist Bioscience tied by winning 8 of the 16 factors compared between the two stocks. Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADPT vs. The Competition Export to ExcelMetricAdaptive BiotechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.92B$3.15B$5.80B$10.16BDividend YieldN/A2.32%5.72%4.60%P/E Ratio-15.9521.2475.0826.39Price / Sales9.71420.70508.41175.01Price / CashN/A44.4425.8129.91Price / Book9.559.6413.596.28Net Income-$159.49M-$53.20M$3.29B$270.38M7 Day Performance3.73%0.07%0.07%1.89%1 Month Performance0.31%4.27%4.57%6.01%1 Year Performance184.97%9.62%76.79%25.26% Adaptive Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADPTAdaptive Biotechnologies3.5427 of 5 stars$13.08+3.7%$12.38-5.4%+183.7%$1.92B$205.22M-15.95790Positive NewsTWSTTwist Bioscience3.9661 of 5 stars$26.25+1.9%$49.40+88.2%-45.2%$1.55B$312.97M-18.10990TXG10x Genomics3.5013 of 5 stars$13.93-0.2%$13.54-2.8%-40.3%$1.74B$610.78M-19.901,240Analyst DowngradeVCYTVeracyte3.6622 of 5 stars$32.46+0.1%$40.90+26.0%-3.2%$2.55B$445.76M98.37790RVMDRevolution Medicines4.191 of 5 stars$41.06+1.4%$72.00+75.4%+5.7%$7.57B$11.58M-9.12250Insider TradeAnalyst RevisionGRFSGrifols3.9957 of 5 stars$10.11-0.2%$10.30+1.9%+4.0%$6.96B$7.81B8.6423,822RYTMRhythm Pharmaceuticals3.2887 of 5 stars$99.77-2.3%$101.57+1.8%+93.5%$6.78B$130.13M-33.15140Positive NewsLEGNLegend Biotech3.2015 of 5 stars$34.62-4.0%$74.22+114.4%-32.7%$6.66B$627.24M-39.342,609Positive NewsABVXAbivax2.3952 of 5 stars$90.00+2.2%$92.33+2.6%+632.7%$6.65BN/A0.0061Analyst UpgradeShort Interest ↑Gap DownRNAAvidity Biosciences2.1127 of 5 stars$48.05-4.6%$67.00+39.4%-3.6%$6.48B$10.73M-13.50190Analyst ForecastCYTKCytokinetics4.3881 of 5 stars$52.09-1.7%$75.38+44.7%-11.5%$6.34B$18.47M-10.21250Positive NewsInsider Trade Related Companies and Tools Related Companies Twist Bioscience Competitors 10x Genomics Competitors Veracyte Competitors Revolution Medicines Competitors Grifols Competitors Rhythm Pharmaceuticals Competitors Legend Biotech Competitors Abivax Competitors Avidity Biosciences Competitors Cytokinetics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADPT) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADPT Stock Alerts